Revenio Group Corporation: The Revenio Icare ic200 intraocular pressure measurement device has been granted marketing authorization in the United States
Revenio Group Corporation, Press release, January 15, 2020 at 10.15THE REVENIO ICARE IC200 INTRAOCULAR PRESSURE MEASUREMENT DEVICE HAS BEEN GRANTED MARKETING AUTHORIZATION IN THE UNITED STATES Icare ic200, the new generation tonometer for intraocular pressure screening for professional use has been cleared by FDA, the Food and Drug Administration of the United States. The product has been previously authorized in both Europe and Japan. The FDA clearance now enables the launch of sales and marketing measures also in the United States. “I look forward with great interest to the launch